Skip to main content
Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

3 Aufrufe
Herunterladen
Pharmazeutisch

Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.

Dosierung

Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Stärke

Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Packungsgröße

Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Form

Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Sicherheitsprofil

Kontraindikationen

Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Nebenwirkungen

Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Verwandte klinische Artikel

Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.

QR Code